Interestingly, in the two lung cancer cell lines the effects of genetic inhibition on the levels γ-H2AX were more pronounced compared to CTPI2 treatment, thus paralleling the differences in the effects of the two treatments on the D-2-HG accumulation (Fig. 1b, c). The gene discussed is H2AX; the disease is lung cancer.